Micronized progesterone: the complete guide

Micronized progesterone is a body-identical hormone prescribed mainly to protect the uterine lining in women with a uterus who take estrogen. It matches the progesterone the ovaries once produced, is usually taken as a capsule at bedtime, and is generally not needed after a hysterectomy. This guide covers how it works, how it is dosed, what side effects to expect, and how it pairs with estradiol.

What is micronized progesterone?

Micronized progesterone is progesterone that has been milled into very fine particles so the body can absorb it reliably when it is swallowed. Progesterone on its own is poorly absorbed by mouth, and micronizing it in an oil base is what makes an oral capsule practical. The hormone itself is body-identical, meaning its molecular structure is the same as the progesterone the ovaries release after ovulation during the reproductive years. That is a statement about chemistry, not a claim of superiority: body-identical simply describes the molecule, and it does not by itself make a medication safer or more effective than another option.

In menopause care it is prescribed as a companion to estrogen rather than as a standalone treatment for hot flashes. Estradiol is what relieves vasomotor symptoms; progesterone is what keeps the uterine lining from being stimulated by that estradiol. Womea prescribes it as micronized progesterone capsules, the standard body-identical form used in guideline-concordant menopause care. Whether it belongs in your regimen at all depends on one question more than any other, which is whether you still have a uterus.

How does micronized progesterone differ from synthetic progestins?

Progestogen is the umbrella term for anything that acts on the progesterone receptor. It splits into two families: progesterone itself, and synthetic progestins such as medroxyprogesterone acetate or norethindrone acetate, which are laboratory-designed molecules that bind the same receptor but are structurally different. Both families can protect the endometrium when dosed appropriately. They differ in how they are metabolized, in their side-effect profiles, and in the trials they have been studied in, which is why the choice is a clinical judgment rather than a default.

You will see claims online that body-identical progesterone is categorically safer than synthetic progestins. That overstates what the evidence supports. Some observational research has reported differences between the two families in breast and cardiovascular signals, but observational data cannot settle the question the way a head-to-head randomized trial would, and no reputable guideline treats one as risk-free. What is fair to say is that micronized progesterone is a well-established, guideline-concordant option that many clinicians reach for first, and that the right progestogen for you is chosen with a licensed clinician who knows your history.

Why does endometrial protection matter?

Estrogen tells the endometrium, the lining of the uterus, to grow. During the reproductive years that growth is balanced every cycle: after ovulation the ovary produces progesterone, which matures and stabilizes the lining, and when hormone levels fall the lining sheds as a period. Systemic estrogen therapy reproduces the growth signal without reproducing that monthly counterbalance. Left unopposed over months and years, that one-sided stimulation can lead to endometrial hyperplasia, an overgrowth of the lining that in some women progresses toward endometrial cancer.

Adding a progestogen restores the balance. This is not an optional refinement or a wellness add-on: it is the reason progesterone appears in the prescription at all, and it is why a clinician will not prescribe systemic estradiol on its own to a woman who still has her uterus. It also explains why taking progesterone erratically matters more than it might seem. Skipping doses does not simply blunt a benefit, it reduces the protection the medication exists to provide, which is worth raising with your care team if you are struggling with the schedule.

Who needs micronized progesterone, and who does not?

The dividing line is anatomical rather than symptomatic. If you have a uterus and you take systemic estrogen, whether as a patch, a gel, or a tablet, you need a progestogen alongside it. If you have had a hysterectomy, there is no endometrium to protect, and guidelines do not recommend routinely adding progesterone to estrogen therapy. That is a meaningful distinction, because progesterone carries its own side effects and its own considerations, and there is no reason to accept them without the corresponding benefit.

• Uterus intact, taking systemic estradiol: a progestogen is required for endometrial protection.
• Post-hysterectomy: progesterone is generally not needed, and estradiol is usually prescribed alone.
• Low-dose vaginal estrogen for genitourinary symptoms: systemic absorption is minimal, so a progestogen is generally not required.
• Perimenopause with a uterus: progesterone is often used cyclically, and a clinician may also use it to help settle erratic bleeding patterns.
• Any unexplained vaginal bleeding: this needs evaluation before or alongside starting therapy, not a prescription written around it.

There are also situations where progesterone is used for reasons beyond endometrial protection, most often in perimenopause where cycles have become unpredictable. That is a clinical decision made case by case. What it is not is a general-purpose supplement: if you have had a hysterectomy and are considering progesterone anyway because of something you read about sleep or mood, that is a conversation to have explicitly with your clinician rather than an assumption to act on. Prescribing is never guaranteed, and the benefit has to be weighed against the risk for you specifically.

Continuous or cyclic: how is micronized progesterone dosed?

There are two established schedules, and both provide endometrial protection when used as prescribed. The difference between them is dose, frequency, and the bleeding pattern you should expect. Which one fits you depends largely on where you are in the menopause transition and on whether a monthly bleed is acceptable to you.

Neither schedule is inherently better. Cyclic dosing tends to be easier to tolerate close to the menopause transition, when the body is still accustomed to a rhythm, and it produces a bleed you can anticipate. Continuous dosing is the usual choice once a woman is clearly postmenopausal and wants to be finished with periods, at the cost of some unpredictable spotting while the lining adjusts. Clinicians also switch women from cyclic to continuous over time, which is a normal part of care rather than a sign anything has gone wrong.

Whichever schedule you are given, take it as prescribed rather than as needed. Progesterone is not a rescue medication that you use on rough nights and skip on good ones. Its protective effect depends on consistent exposure over each cycle, so a dose missed here and there is worth mentioning at your follow-up so your clinician can decide whether the schedule needs to change.

Why is progesterone usually taken at bedtime?

Oral micronized progesterone is broken down in the liver into metabolites that act on the same receptors in the brain that respond to calming signals, which is why it commonly causes drowsiness and, in some women, a brief lightheaded feeling within an hour or two of the dose. Taken in the morning that is a genuine nuisance and, for anyone driving or working, a hazard. Taken at bedtime the same effect lands where it is useful, and it is the reason nearly every prescription specifies a bedtime dose. Take it consistently, and take it with the same relationship to food each night, since a heavy meal changes how much is absorbed.

Many women do report that they sleep better on bedtime progesterone, and it is a reasonable thing to hope for. It is not, however, something to count on. The sedating effect varies considerably between individuals, some women notice nothing at all, and a minority feel groggy the next morning rather than rested. Sleep in midlife also has more than one cause: night sweats, anxiety, and the changes in sleep architecture that come with the menopause transition are separate problems that respond to different parts of a treatment plan. If sleep is your main reason for seeking care, it is worth reading how the whole picture fits together on sleep and menopause rather than treating progesterone as the answer on its own.

What side effects should you expect?

Micronized progesterone is generally well tolerated, and most side effects are mild and tend to settle within the first few cycles. Knowing which ones are expected and which ones warrant a message to your clinician is the practical part.

• Drowsiness or a mild lightheaded feeling within a couple of hours of the dose, which is why it is taken at bedtime.
• Bloating, fluid retention, or a heavier feeling in the abdomen, often most noticeable in the first weeks.
• Breast tenderness, which usually eases as your body adjusts to the regimen.
• Mood changes: some women feel calmer, and a minority feel low or irritable, which is worth reporting rather than tolerating.
• Spotting or irregular bleeding, common in the early months of continuous dosing and expected as a scheduled bleed on cyclic dosing.
• Headache or nausea, less common, and usually manageable with a change in timing or dose.

Some things should prompt a call rather than patience. Bleeding that is new after a settled stretch, unusually heavy, or persistent needs evaluation, because the point of endometrial protection is to catch a problem with the lining early rather than assume it away. Chest pain, shortness of breath, calf swelling, sudden severe headache, or vision changes are reasons to seek urgent medical care, as they are with any hormone therapy. Persistent low mood is also a reason to make contact, since a different progestogen or a different schedule sometimes resolves it.

What should you expect over the first few months?

Hormone therapy is titrated rather than switched on. The first months are about your body adjusting to the regimen and your clinician learning how you respond, which means some patience and honest reporting on your side.

The other thing worth setting expectations about is dose. The goal is the lowest dose that provides adequate endometrial protection and fits your symptoms, not the highest dose you can tolerate. Adjustments are normal and are not a sign that the plan failed. Since Womea includes secure messaging with your care team in the price of your medication, raising a side effect early is the cheapest way to fix it. If you want to compare what a course of therapy involves before you commit, the current figures live on the treatments pricing section.

How does micronized progesterone pair with estradiol?

The two hormones do different jobs and are prescribed as a pair for that reason. Estradiol is the component that treats the symptoms most women come in for: hot flashes, night sweats, disturbed sleep, and the genitourinary changes of menopause, and it is also the component that supports bone density. Progesterone does not treat vasomotor symptoms. Its role is to make estradiol therapy appropriate for a woman with a uterus by protecting the lining. Understanding that division of labor helps, because it explains why a dose change to one is not necessarily a dose change to the other. The companion piece on estradiol covers the estrogen side of the regimen in detail.

In practice the pairing looks like daily estradiol by patch, gel, or tablet, with progesterone taken at bedtime either every night or for 12 to 14 days a month. Route matters for estradiol, since transdermal delivery bypasses first-pass liver metabolism and is often preferred for women with particular risk factors, and that decision is made during the visit. For a shorter overview of the progesterone component specifically, the article on micronized progesterone benefits, timing, and side effects covers the essentials in less depth than this guide.

How do you start, and what does the visit involve?

Menopause is diagnosed from your symptoms and history, so no routine bloodwork is required to begin. You complete a detailed symptom and health-history assessment, then have a live video or phone visit with a US-licensed clinician who reviews your history, discusses the benefits and the risks with you, and determines whether hormone therapy is appropriate. If it is, the clinician selects the regimen, including whether you need progesterone and on which schedule, and the medication ships to your door. There is no in-person clinic visit, but the live visit itself is required and is not something to look for a way around.

The clinician will want to know about your surgical history, particularly whether you have had a hysterectomy, your bleeding pattern, your personal and family history of clot, cardiovascular, and hormone-sensitive conditions, and the medications you already take. Some of that history rules hormone therapy out, and prescribing is never guaranteed. Where it is appropriate, the plan is built around your circumstances rather than a template, and it is revisited as your symptoms change.